Kidney
RYZ512-001
A Phase 0 Imaging Study to Assess the Feasibility, Biodistribution, and Dosimetry of a Carbonic Anhydrase IX (CAIX) Binder in Subjects with Metastatic Clear Cell Renal Cell Cancer (RCC).
Trial overview
Clinical Area
Theranostics
Disease
Kidney
Disease site
Genitourinary (GU)
Study Phase
0
Trial Identifiers
Registration number: NCT07671417
Principal Investigator(s)
··
··